精华 苦辣酸甜难书尽,成败得失笑谈中

OK, a long day indeed, and let me conclude with a what if

Suppose Ian Clark is not added onto DNDN BOD for the purpose of a Provenge ROW partnership but for something else rather, such as Nuevenge or TRP-P8 or CEA. The stock prospect is even brighter if that is the case. But one has to have the patience to hold for very long to benefit financially. With or without an immediate Provenge ROW partnership, DNDN will be a success and I have a very patient and long vision for holding it, despite being shaken out a couple of times in the past. Weak hand no more.
 
One final caution before I resort to bed

Nearly all the stocks underlying my portfolio are close to or at year's high except SVA. I don't recommend anybody buying or selling. It is your money and you are the only one who can safeguard it. Good luck!
 
SVA PR out, climbing in PM

Co received certificate of approval to distribute its H5N1 vaccine in HK. Appears more news to come in the pipeline. An order would be nice!
 
Being a market mover, will INTC push markets higher?

INTC beats both top and bottom lines handsomely with upbeat guidance. The stock is surging in AH. Bank heavy weights are on tap to report tomorrow. Pending on the results, are these enough to push DOW over 10K in the near future? Things are looking up, folks.
 
不幸的被AIG套牢了,47.x入的货。荣幸的当上AIG小小小股东。
 
Big day in store

JPM reports before the bell; retail sales due out at 8:30am; FED latest policy meeting minutes release at 2pm.

Futures are exploding as of 5:30am. It may be a great day to book some profits. Plan ahead if you are so inclined.

Volume has been low, suggesting that money is on the sideline looking for entry and implying that this market wants to go higher. Should indexes break and hold key milestones, all hell will break loose. Beware of losing stocks, though, as tax loss selling may start soon.
 
JPM ER out: EPS of $.82 vs EPS estimate of $.49

This is a blowout, folks. Futures are rising more after this ER.
 
Roche ER and conference call tomorrow

I assume Ian Clark will be at the CC for Q&A. Suppose, someone asks, "Ian, you are just appointed (oh no, elected per the PR) a DNDN BOD member and received over $145K for free at yesterday's close. How did the first BOD meeting go? Can you elaborate the steps leading to this appointment and your/Roche's intensions for your sitting on that BOD?" He can dance in whatever ways and say whatever words he likes on earth but one answer I don't like to hear is this, "Oh well, I sit on that BOD not for fun nor for the fees. Roche wants me on that BOD to look after our interests. We intend to sign an ROW PA soon and we will buy into DNDN shares on top of the hefty upfront cash we will pay them for the previlige of a partnership. We are willing to pay up to 120% premium pre-FDA approval to own a piece of a forthcoming cancer treatment paradigm shift. The price we will have to pay will be a lot higher post FDA approval and SNY is currently looking over our shoulders for a gift. We don't want SNY to have Provenge, and Nuevenge, TRPP8, CEA down the road. As far as the first BOD meeting goes, that son of a bitch Mitch is a smart, stubborn and nerdy visionary with an ego bigger than life, very tough to handle indeed. But they got the IMPACT results for Provenge, nothing we can do except to live with the terms they dictate. We don't want SNY to eat our lunch."
 
More imaginary words from the mouth of Ian Clark

I am making this stuff up just for fun, folks. Shall we continue?

After a moment of silence and reflection at the CC Q&A, Clark goes on. “As you know, I could have become the CEO of an independent DNA but Roche bought into Genentech in the early days. At $92 per share after many forward splits (Roche did offer up to 93 after its initial offer of 89 and finally ended up buying all shares @95), DNA shareholders could not simply resist Roche’s offer on the table. They threw in the towel and there went my dream of becoming the CEO of an independent DNA. This Mitch boy really wants to remain independent. He managed to get the authorization of issuance of 135M shares at the AGM in last June as a poison pill to guard against any hostile takeover bid. This guy is simply tough, too tough, to beat. He is a very good chess player, planning at least 3 moves ahead.

Now, let me make some comments. Mitch’s mother died of breast cancer, and he vowed to beat cancers at med school. That has been all he was doing all his life post graduation. I wish him best of lucks and I think he will have his wishes satisfied. I know Roche will eventually buy off DNDN. I have no idea at what price per share and after how many forward splits. But we will for sure buy them off. The greatest challenge I will surely face is how I will get along with this son of a bitch Mitch boy as a colleague after the buyout. Seattle produces egos like Gates and Henney. Mitch is no less than a wannabe. But I am a big ego in my own way and I have no idea whose is even bigger. Time will provide the ultimate test. For now, I greatly enjoy collecting the DNDN director fees. Very soon, those free shares may be worth a lot more. Thank you very much and have a nice day!”


To conclude, I am only about 30% loaded with DNDN shares and options.
 
Another big day ahead

GS and C ERs are due out before the opening bell; CPP and weekly jobless claims are also on tap at 8:30am.

BAC reports tomorrow.

Are JPM's results hard to follow or indicative of what is in store for other major financials? Can DOW hold 10K? Will S&P 500 flirt with 1.1K? Million-dollar questions to ask for sure.

Futures are little changed as of 5:16am.
 
BAC ER out: big miss and stock is taking a heavy beating

on top of giving back yesterday what it gained the day earlier.

Fear may drive it much lower short-term.
 
This is indeed a bloody day, buying opportunity too

I attempted to buy some cheap BAC and LVS shares. My limit orders sent before leaving for work were off about a nickle and 35 cents (I like round numbers and entered 17 and 16, respectively, which of course resulted in no fills. But I did open a sizable position in ZAUAH @ 1.45 during lunch hour in addition to getting a little UQBKG (also @ 1.45).

The way I read it, two market movers (GE and BAC) reported really bad Q on an OE day, yet the bears only managed to do this much damage. This is music to this die-hard long's ears! If your perspective is more than a day or a week, there isn't much to worry about, IMO, provided you have picked the right horses to ride.
 
DOW will have 11K and S&P 500 1.2K to start with in the new year

[FONT=宋体]当上证指数破六千时,朋友们高喊“奥运会见万”,我写下了题为“上证指数见万前先见两千”的小文。本想贴到网易财经的,朋友不让。如果中国股市让做空,我当时会狠狠地空一把的。不久后被“笑”指中国股市的狂跌都是因为我的“乌鸦嘴”.[/FONT]

When DOW was around 8K, I said to colleagues that DOW would close the year above 10K. None of them believed me and all said I was out of mind. Now that I am ahead about 2 months and a half, let me go out of the limb again by predicting that DOW will have 11K and S&P 500 1.2K to start the new year with.

Group favourites (I don’t like the concept of sector, too big to work with): financials (banks, insurance and brokerage, specifically); hospitality/entertainment/gaming; biotech (this space is so vast that one has to be very choosy, still not to be confused with healthcare); travel and airline; energy and base materials; selected high-tech (again, it is so vast).

Accordingly, I currently own BAC, DNDN, SVA, MGM, and LVS. I have shares for trading and LEAP calls for holding. I need to open positions in travel and airline, energy and base materials, and high-tech but can’t find the handle at the moment. I would greatly appreciate if someone could suggest a few candidates in energy and base materials, and high-tech --- I am more interested in emerging leaders, not necessarily current leaders.

Have made a few good hands but also suffered a number of blunders, notably ARNA and ELN.
 
gas?

I enjoy reading your writing, and it is kind of creative. :cool:

I noticed you closed your DVAX position, and could you please let us know the reason?

I bought hnu.to(gas.to) since it is said that this winter would be very cold, and the gas price is very low. What do you think?


Thanks.
 
I bought hnu.to(gas.to) since it is said that this winter would be very cold, and the gas price is very low. What do you think?
我今年在我的RSP中反复买来卖去hou.to,hnd.to.hnu.to这几个ETF,收益还算可以(over 70%)。
 
后退
顶部